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Abstract Expansion of a polyalanine stretch from 10 to 12^17
residues in the N-terminus of the protein PABP2 has been im-
plicated in the genetically acquired disease oculopharyngeal
muscular dystrophy, characterized by nuclear protein deposits.
Here we report a correlation between the structural properties
and cell toxicity of two peptides mimicking the N-terminal do-
main of PABP2: one containing seven and the other 11 unin-
terrupted alanine residues. Consistent with earlier observations,
the longer peptide (11-ala) was found to adopt L-sheet structure
while the shorter one (7-ala) formed K-helix over a wide range
of concentrations (V20^500 WM). We observed that treatment
with 11-ala resulted in signi¢cantly enhanced death of Chinese
hamster V79 cells, compared to the e¡ect of treatment with 7-
ala, via the cytochrome c mediated apoptotic pathway. Increases
in caspase 8 and caspase 3 activity were also observed in human
cells (K562) treated with 11-ala. These results indicate that the
toxicity of pathogenic peptides is directly linked to their L-sheet
structure and also support recent observations that small oligo-
meric species of peptides and proteins are the key toxic elements
in causing protein aggregation diseases.
9 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Expansion of the repeating trinucleotide sequences CAG
and GCG, causing expansion of uninterrupted sequences of
glutamine and alanine, respectively, in proteins has been iden-
ti¢ed as the causative mutations in a large number of inherited
diseases [1^8]. An essential feature of polyglutamine expan-
sion diseases is the presence of proteinaceous deposits in the
neuronal cells of patients, leading to the term ‘protein depo-
sition disease’ being coined for them [1]. Among the alanine
expansion diseases, however, oculopharyngeal muscular dys-
trophy (OPMD) is the only one to exhibit the characteristic
nuclear protein aggregation and ¢lamentous nuclear inclu-
sions in muscle ¢bers [9,10]. The autosomal dominant form
of OPMD is caused by short expansions of a (GCG)6 repeat
to (GCG)813 in the PABP2 gene, which results in the expan-
sion of a polyalanine stretch from 10 to 12^17 alanines in the
N-terminus of the protein [4]. Mutated PABP2 is able to in-
duce nuclear protein aggregation and to lead to nuclear frag-
mentation [10].
A number of recent studies have demonstrated that aggre-
gates of polypeptide tracts or fragments of protein implicated
in protein misfolding diseases are directly toxic to cells. For
instance, high levels of intracellular aggregates and nuclear
fragmentation were observed in cells expressing green £uores-
cent protein (GFP) fused to 19^37 alanines, when compared
to cells expressing GFP alone or GFP fused to seven alanines
[11]. On the other hand, species formed early in the aggrega-
tion of non-disease associated proteins, such as the SH3 do-
main from bovine phosphatidylinositol 3P-kinase and the ami-
no-terminal domain of the Escherichia coli HypF protein,
have also been shown to be inherently highly cytotoxic [12].
Such results point to the need for exploring the role of other
factors, e.g. protein sequence and conformation, in protein
aggregation that may have a bearing on cell viability and
thus would be relevant for the diseases.
One such factor is the length of the polypeptide tracts im-
plicated in the disease. Not much is known about the relation
between the lengths of polyalanine sequences and their patho-
logical properties. Since expansions of 12 or more uninter-
rupted alanines in PABP2 are known to cause OPMD, we
decided to look at peptides associated with this disease in
the transition region between the monomeric and aggregated
species and their concomitant e¡ect, if any, on cells in culture.
We report here a correlation between the structural tenden-
cies and the e¡ect on viability of cells in culture of two pep-
tides mimicking the N-terminal polyalanine segment of
PABP2: one containing seven and the other 11 successive
alanine residues. In addition to the N-terminal sequence of
PABP2 (polyalanines preceded by a methionine and followed
by a glycine), each contained a lysine at the N-terminus (to
enable solution studies) and a tyrosine at the C-terminus to
enable peptide concentrations to be determined spectrophoto-
metrically. The sequences used were Ac-Lys-Met-(Ala)7-Gly-
Tyr (7-ala) and Ac-Lys-Met-(Ala)11-Gly-Tyr (11-ala).
Polyalanine tracts containing s 10 alanines have previously
been shown to form L-pleated sheet complexes in solution,
with s 50% complex formation occurring for peptides con-
taining v 12 alanines [13]. Using circular dichroism (CD)
spectroscopy we have veri¢ed that the two peptides used in
this study adopt distinctly di¡erent secondary structures in
solution. While the shorter peptide (7-ala) adopted exclusively
K-helical structure, the longer one (11-ala) formed L-sheet and
favored intermolecular association with increasing concentra-
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tion. The important new result found in this study was that
11-ala induced signi¢cantly higher levels of apoptosis com-
pared to 7-ala when both were presented to Chinese hamster
V79 cells in culture. To our knowledge, this is the ¢rst report
of cellular toxicity of conformation speci¢c (L-structure form-
ing) oligomeric polyalanine peptides, raising the possibility
that such peptides may act as useful model systems for eluci-
dating the biochemical pathways of a class of protein misfold-
ing diseases.
2. Materials and methods
2.1. Chemicals and antibodies
Hoechst 33258 dye and RNase A were obtained from Sigma Chem-
icals (USA) and proteinase K was from Life Technologies (USA).
Nonidet P40 and nitroblue tetrazolium/5-bromo-4-chloro-3-indolyl
phosphate (NBT/BCIP) tablet were obtained from Boehringer Mann-
heim (Germany). Other molecular biology grade ¢ne chemicals were
procured locally. Anti-cytochrome c antibody was from PharMingen
(Becton Dickinson, USA) and secondary antibody (anti-mouse) from
Santa Cruz Biotechnology (USA).
2.2. Synthesis of oligopeptides
Peptide synthesis was performed on a LKB 4175 peptide synthesizer
using the Fmoc polyamide active ester chemistry and solid phase pep-
tide synthesis technique. They were cleaved with a solvent mixture
containing 94% tri£uoroacetic acid, 2% anisole, 2% ethanedithiol
and 2% phenol at room temperature, precipitated by addition of di-
ethyl ether, puri¢ed on a reversed phase C18 high performance liquid
chromatography column and stored at 320‡C in lyophilized pow-
dered form. The purity of the peptides was con¢rmed by mass spec-
troscopic analysis on a MALDI-TOFSPEC 2E instrument (Micro-
mass, UK).
2.3. Spectroscopic measurements
CD spectra were recorded on a Jasco J-720 spectropolarimeter us-
ing cylindrical quartz cuvettes of path length 1, 2 and 5 mm. Each
spectrum represents the average of ¢ve successive scans performed at
a scan speed of 20 nm/min. Appropriate baseline subtraction and
noise reduction analysis were performed. At concentrations higher
than 5U1035 M the peptides were dissolved in a 60% acetonitrile^
40% water mixture. For temperature dependent studies, a water jack-
eted cylindrical quartz cuvette of path length 2 mm was used in con-
junction with a NESLAB RT-110 circulating water bath. Peptide
concentrations were determined from tyrosine absorbance, using a
molar extinction coe⁄cient of 1280 M31 cm31 at 280 nm [14].
2.4. Electron microscopy (EM)
Samples of 11-ala for EM were prepared by incubation of a 300 WM
(0.4 mg/ml) solution of the peptide in phosphate bu¡ered saline (PBS,
pH 7.4) at 65‡C for 24 h. The samples were spread on carbon coated
copper grids and stained with 2% (w/v) uranyl acetate in water. The
air dried sample was visualized on a Hitachi H-600 TEM at 75 kV.
2.5. Cell culture
Chinese hamster V79 (male lung, ¢broblast) cells were obtained
from the National Institute of Virology, Pune, India. Cells were rou-
tinely grown as a monolayer in plastic Petri dishes using Eagle’s
minimal medium supplemented with dialyzed goat serum (complete
medium) at 37‡C in a humid atmosphere containing 5% CO2 [15].
2.6. Treatment of cells with peptides
V79 cells were plated (106 per 100 mm Petri dish) in the complete
medium and, after overnight incubation, treated with 20 WM ¢nal
concentration of peptides (7-ala, 11-ala, bombesin and N-melanocyte
stimulating hormone) in 5.5 ml complete medium. Cells were then
allowed to grow for another 36 h. At the end of the treatment the
medium was removed, washed with PBS, trypsinized and suspended in
PBS. Cells were counted under the microscope on a hemocytometer.
Cells grown without addition of peptides were used as control.
Growth inhibition by treatment with the peptides was calculated by
dividing the number of viable cells obtained after treatment with pep-
tides by the number of such cells obtained in untreated control. Cells
were then used for detection of nuclear fragmentation, nucleosomal
ladder formation or cytoplasmic cytochrome c release by Western blot
as described below. Each experiment was repeated two to four times.
2.7. Analysis of nuclear and DNA fragmentation
Cells collected as above were washed with PBS twice, re-suspended
in 70% ethanol (105 cells/ml) and kept at 4‡C for 1 h for ¢xation.
They were then stained with 1 mM Hoechst in PBS in the dark at
room temperature for 5 min and observed under a £uorescence micro-
scope (Olympus BX60 with appropriate attachments, Japan). About
200^500 cells were counted. Cells with intact nuclear morphology
(normal) and fragmented nuclei (apoptotic cells) were determined
and the fraction of cells with apoptotic nuclei was calculated.
DNA fragmentation assay was performed using a method incorpo-
rating some modi¢cations of a standard one [16]. In brief, exponen-
tially growing cells were treated with 20 WM peptides for 36 h as
described above, after which they were harvested by trypsinization,
washed with PBS and collected by centrifugation. The cell pellets were
lysed in lysis bu¡er (50 mM Tris, 20 mM EDTA, 1% Nonidet P40) for
10 min at room temperature. The lysate was centrifuged at 2800 rpm
and the supernatants collected. This process was repeated three times.
The supernatant, after addition of sodium dodecyl sulfate (SDS, ¢nal
concentration 1%), was treated with RNase A (¢nal concentration 0.1
mg/ml) overnight at 56‡C, followed by proteinase K (¢nal concentra-
tion 0.1 mg/ml) for 6 h at 56‡C. The lysate, after addition of a half
volume of 10 M ammonium acetate, was treated with 2.5 volumes of
absolute ethanol overnight at 320‡C. The DNA was then precipitated
by centrifugation at 12 000 rpm at 4‡C for 15 min. After drying, the
pellet was dissolved into sterile water and mixed with a gel loading
dye (0.25% bromophenol blue, 40% sucrose), separated on 1.5% aga-
rose gel and visualized under UV illumination after staining with
ethidium bromide (0.5 Wg/ml). The gel was photographed. Untreated
cells were processed in the same way and used as control.
2.8. Western blotting
Chinese hamster V79 cells treated with peptides for 24 h and un-
treated control cells were harvested, washed twice with PBS and cy-
toplasmic extracts were prepared using standard methods [17]. Protein
estimation was done according to Lowry’s method: 20 Wg protein was
resolved on 15% polyacrylamide gel (acrylamide:bis-acrylamide 19:1)
containing 0.1% SDS, transferred to nitrocellulose paper (Hybond
ECL, Amersham Life Science, UK) and treated with blocking solu-
tion (5% bovine serum albumin in 25 mM Tris, 0.15 M NaCl, TBS)
for 2 h at room temperature with constant shaking in an orbital
shaker. Anti-cytochrome c (1:2000 dilution) was used to react over-
night with separated proteins on the membrane in TBS containing
0.05% Tween 20 at 4‡C. The blot was washed four times with 5.0
ml TBS containing 0.05% Tween 20, followed by treatment with alka-
line phosphatase conjugated anti-mouse immunoglobulin G (at the
same dilution as that of the primary antibody in TBS) for 2.5 h at
room temperature. After washing the membrane four times with bu¡-
er and treating it with NBT/BCIP (substrate for alkaline phosphatase)
to visualize the proteins, the blot was scanned and the intensities
recorded.
3. Results and discussion
Fig. 1 shows the far UV CD spectra of the peptides over an
almost 50-fold range of concentrations. The strong positive
band at 192 nm and the twin minima at 207 nm and 222
nm in Fig. 1a show that 7-ala exists primarily in the K-helical
conformation over the whole range. The degree of helicity
(a222 nm) shows little variation with concentration while de-
creasing linearly with increasing temperature (inset), as ex-
pected for a simple monomeric species. For 11-ala, the strong
positive band below 200 nm and the much weaker negative
band around 220 nm (Fig. 1b) are indicative of formation of a
L-type structure. With increase of concentration, the intensity
of the positive band increases markedly and its position shifts
to the red (by about 5 nm overall), a feature also observed
in polyglutamine peptides and attributed to widening of the
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L-sheets and/or formation of tightly linked and twisted inter-
molecular species [18]. The strong nature of the intermolecular
association is also indicated by the thermal stability of a218 nm
(inset), which characterizes the L-sheet structure. These results
verify the structural transition of polyalanine sequences of
length s 10 residues from random coil/K-helix to L-pleated
sheets, as reported earlier by Blondelle et al. [13].
Fig. 2 shows a typical electron micrograph of the ‘aged’
11-ala peptide, where amorphous clumps of average dimen-
sion 30^50 nm are visible. Polyalanine aggregates of similar
size have been reported, though no amyloid-like ¢brillar
forms or networks were detected in the present case even after
extended periods of ageing [13].
To explore the deleterious e¡ects of the L-structure forming
peptides, equal numbers of Chinese hamster V79 cells were
treated with 20 WM of the peptides (7-ala, 11-ala) for 36 h.
Cells treated with the 11-ala peptide showed a signi¢cant de-
crease in growth compared to untreated control. A small de-
crease in growth occurred for cells treated with 7-ala, while
the number of untreated cells remained unchanged. Averaged
results of three to ¢ve independent experiments indicated that
treatment with 11-ala inhibited cell growth by 55%, whereas
for the 7-ala treated cells this value was 18%. This di¡erence
was statistically signi¢cant (P=0.03).
The morphology of the nuclei was examined after staining
with the DNA binding dye Hoechst 33258. Cells treated with
11-ala had a much higher number of nuclei with typical mor-
phology for nuclear fragmentation. A composite picture is
shown in Fig. 3a. The average number of untreated (control)
cells that exhibited apoptosis was (9T 9)%. This value was
(15T 8)% and (29T 9)% for 7-ala and 11-ala treated cells,
respectively. The di¡erence between the values for the un-
treated cells and the 7-ala treated cells was not statistically
signi¢cant (P=0.36). However, this di¡erence was statistically
signi¢cant (P=0.02) for cells treated with the 11-ala peptide.
The induced frequency of apoptotic cells for treatment
with 7-ala and 11-ala peptides was signi¢cantly di¡erent
(P=0.002), as shown in Fig. 3b. A comparison of the ability
of di¡erent concentrations of 11-ala to induce apoptosis is
Fig. 1. Concentration dependent CD spectra of the peptides at 25‡C. a: For 7-ala at concentrations 4.25U1034 M (888), 2.12U1034 M (^ ^ ^),
1.06U1034 M (WWWWWW), 5.31U1035 M (^WW^WW^) and 2.65U1035 M (^W^W^). Inset shows temperature dependent ellipticity at 222 nm. b: For 11-ala
at concentrations of 4.2U1034 M (888), 2.8U1034 M (^ ^ ^), 1.4U1034 M (WWWWWW), 7.0U1035 M (^WW^WW^), 3.5U1035 M (......) and 8.7U1036 M
(^W^W^). Inset shows the temperature dependent ellipticity at 218 nm.
Fig. 2. Electron micrograph of negatively stained samples of 11-ala
prepared by incubation at 65‡C for 24 h. Magni¢cation: 60 000U.
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shown in Fig. 3c. An apoptotic level of 40% was reached for
treatment with 100 WM of peptide.
We also investigated the ability of the peptides to induce the
nucleosomal ladder, a hallmark of apoptosis. The result of a
typical experiment is shown in Fig. 4a. It is evident that 11-ala
could induce the nucleosomal ladder and the intensities of the
ladders were higher than in the untreated control. 7-Ala treat-
ment also resulted in a similar pattern as that of the control
(data not shown). This di¡erential result is similar to that
observed with nuclear morphology described above.
In apoptosis, cytochrome c ^ which usually remains in the
mitochondria ^ is released in the cytoplasm and in turn acti-
vates the caspase cascade leading to nucleosomal ladder for-
mation. In the conditions of our experiments, untreated con-
trol cells also released a small amount of cytochrome c in the
cytoplasm. The extent of cytochrome c release varies from one
experiment to another. The result of a typical experiment is
shown in Fig. 4b, in which the intensities of the bands re£ect
an eight-fold increase of cytochrome c release in cells treated
with 11-ala, compared to untreated control.
To investigate the role of caspase 8 in the observed apopto-
sis induction by 11-ala, we treated the human cell line K562
with 20 WM peptide (¢nal concentration) for 20 h. Similar to
what we found with Chinese hamster V79 cells, such treat-
ment inhibited the growth of cells, increased the release of
cytochrome c and caspase 8-like activity. Caspase 8 and cas-
pase 3 activities were detected £uorometrically using commer-
cially available kits (Chemicon International, USA and Phar-
Mingen (Becton Dickinson), USA for caspase 8 and caspase
3, respectively) following methods recommended by the man-
ufacturers. In a typical experiment we observed 45% cell
growth inhibition and V3-fold increase in cytochrome c re-
lease over the control (data not shown). In the caspase 8
assay, there was aV10-fold increase in £uorescence over un-
treated control (from 37 to 390 in arbitrary units (au)). For
the caspase 3 assay, a two-fold increase in £uorescence over
untreated control was detected (83 to 163 au). This set of data
indicates that treatment with 11-ala in conditions where they
formed L-structures increased apoptosis of cells by the caspase
8 mediated pathway, together with cytochrome c release and
caspase 3 activation. Although increased caspase 8 activity
and apoptosis have been reported in cells expressing patho-
logically long polyglutamine sequences, this study is the ¢rst
to report similar e¡ects of polyalanine peptides in a confor-
mation speci¢c manner [19].
Polyglutamine stretches of length v 37 in proteins have
been implicated in a number of neurodegenerative diseases
and are known to form aggregates as nuclear inclusion bodies
and induce apoptosis [19]. However, the role of these aggre-
gates in the molecular pathogenesis of the diseases is unclear.
While formation of aggregates and nuclear inclusions has
been shown to precede neurological abnormality in Hunting-
ton’s disease model systems, observations dissociating aggre-
gation formation from cell death have also been reported [20].
Treatment of cells with non-disease associated proteins in
conditions favoring aggregate formation was found to induce
toxicity, although the type of cell death (apoptosis or necrosis)
in such cases was not determined [12,21]. Treatment of neuro-
blastoma cells with mutant and wild type K-synuclein that are
capable of aggregate formation was found to induce nuclear
fragmentation, an indication of apoptosis [22]. In both instan-
ces the toxic species formed highly organized amyloid-like
¢brillar structures on ageing, although cytotoxicity in the ¢rst
case was far more pronounced for the rapidly formed non-
Fig. 3. Induced apoptosis as detected by nuclear morphology of
Chinese hamster V79 cells stained with Hoechst 33258 under a £uo-
rescence microscope. a: Typical examples of normal and apoptotic
morphology. b: Bar diagram of induced apoptosis (determined by
subtracting the frequencies obtained for untreated control cells) re-
sulting from treatment by the two peptides. c: Comparison of di¡er-
ent concentrations of the 11-ala peptide for their ability to induce
apoptosis.
Fig. 4. Detection of apoptosis by nucleosomal ladder formation and
cytochrome c release into the cytoplasm. a: DNA fragmentation
into nucleosomal ladders: lane 1 represents the untreated control,
while lane 2 represents cells treated with 11-ala. b: Cytochrome c
release: lanes are labeled at the top as cont (untreated control),
7-ala and 11-ala (treated with 7-ala and 11-ala, respectively).
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¢brillar aggregates than for the longer ¢lamentous structures
adopted by the proteins later during incubation. In our experi-
ments demonstrating apoptosis induction by 11-ala, patholog-
ical behavior was not correlated with large scale amyloid-type
aggregate formation. Although incubation of 11-ala did pro-
duce amorphous clumps, amyloid-like ¢brillar forms were not
detected even after extended ageing. This result lends credence
to the recent hypothesis that small oligomers preceding ¢bril
formation may be the primary toxic species in causing disease
[12,21,23].
In summary, we have shown that a L-sheet forming peptide
containing 11 successive alanine residues shows concentration
dependent intermolecular association and is highly e¡ective in
inducing apoptosis, a trait not exhibited by a related peptide
containing a stretch of seven alanines that adopts K-helical
conformation over the same range of concentrations. That
apoptosis was mediated through the mitochondrial pathway
was indicated by the release of cytochrome c in the cytoplasm.
At this point it is not clear whether or how these peptides
enter the cells. It has recently been shown that polyglutamine
aggregates can enter cells and induce apoptosis, possibly
through the activation of caspase 8 or caspase 10 [24^26].
The detection of increased caspase 8-like activity induced by
11-ala suggests that this could also be the case here.
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